Please login to the form below

Not currently logged in

Santen Pharmaceutical

This page shows the latest Santen Pharmaceutical news and features for those working in and with pharma, biotech and healthcare.

NICE no for new eye disease drug

NICE no for new eye disease drug

NICE's preliminary recommendation has been to ask Santen Pharmaceutical for more information on Ikervis (ciclosporin) for treating severe keratitis in adults with dry eye disease which has not improved despite

Latest news

  • Meeting with resistance

    Several pharmaceutical companies appear to have recently found ways of overcoming the manufacturing obstacles. ... Low-grade B-cell lymphoma; mantle cell lymphoma. Japan. Diquafosol. Diquas Ophthalmic Solution 3% (Santen Pharmaceutical).

  • Thin on the ground

    UK. Dorzolamide/timolol. Cosopt (Santen Pharmaceutical Co). Glaucoma and ocular hypertension. Japan. ... Fera Pharmaceuticals. High intraocular pressure. US. Omeprazole/sodium bicarbonate. Par Pharmaceutical Companies.

  • News in Brief, May 30, 2007

    They also did not dismiss a combination of two of the pharmaceutical industry's biggest companies. ... Japan. He has over 30 years experience within the pharmaceutical industry. Currently, Muramatsu is a non-executive director of Santen Pharmaceutical

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Deal Watch table for March 2014 Deal Watch table for March 2014

    265.3. Takeda Pharmaceutical/ Otsuka Pharmaceutical. Co-promotion. TAK-438 (vonoprazan fumarate) for acid-related diseases (NDA filed JP). ... 22. Tracon Pharmaceuticals/ Santen Pharmaceutical Co. Licence. Tracon's anti‐endoglin antibodies, including

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Luis Iglesias heads Santen EMEA Luis Iglesias heads Santen EMEA

    president and chief operating office of parent company Santen Pharmaceutical. ... Iglesias initially joined Santen in 2017 as its senior vice president, commercial EMEA and brought with him more than 25 years’ experience in pharmaceuticals in Europe

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...